In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R126638
Authors:
Open Access
- 1 February 2004
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (2) , 388-391
Abstract
R126638 is a new triazole agent with potent antifungal activity in vitro against various dermatophytes, Candida spp., and Malassezia spp. Its activity against Malassezia spp. in vitro was superior to that of ketoconazole, the agent currently used for the treatment of Malassezia -related infections. R126638 showed activity comparable to or lower than that of itraconazole against dermatophytes in vitro; however, in guinea pig models of dermatophyte infections, R126638 given orally consistently showed antifungal activity superior to that of itraconazole, with 50% effective doses (ED 50 s) three- to more than eightfold lower than those of itraconazole, depending on the time of initiation and the duration of treatment. The ED 50 of R126638 in a mouse dermatophytosis model was more than fivefold lower than that of itraconazole. These data indicate that if the effects of R126638 seen when it is used to treat animals can be extrapolated to humans, the novel compound would be expected to show effects at doses lower than those of existing drugs and, hence, present a lower risk for side effects.Keywords
This publication has 9 references indexed in Scilit:
- Antifungal agents: mechanisms of actionTrends in Microbiology, 2003
- New Yeast Species, Malassezia dermatis , Isolated from Patients with Atopic DermatitisJournal of Clinical Microbiology, 2002
- The genus Malassezia with description of four new speciesAntonie van Leeuwenhoek, 1996
- Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automationAntimicrobial Agents and Chemotherapy, 1995
- The anti‐Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazoleMycoses, 1995
- P450 inhibitors of use in medical treatment: Focus on mechanisms of actionPharmacology & Therapeutics, 1995
- Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agentsAntimicrobial Agents and Chemotherapy, 1992
- Estrogens and InfectionClinical Infectious Diseases, 1991
- Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.1991